Allergic fungal sinusitis. A naso-sinusal specific hyperreactivity for an infectious disease?

C Corradini1, M Del Ninno, D Schiavino

  • 1Institute of Otorhinolaryngology, University Cattolica del Sacro Cuore, Rome, Italy.

Insights

Allergic fungal sinusitis (AFS) may not involve IgE-mediated hypersensitivity. Fungal presence in nasal secretions doesn't correlate with allergic status in AFS patients.

Area of Science:

  • Otorhinolaryngology
  • Allergology
  • Mycology

Background:

  • Allergic fungal sinusitis (AFS) is a rare condition affecting immunocompetent adults with chronic rhinitis or nasal polyposis.
  • It presents a diagnostic challenge, particularly regarding the role of fungal presence and host immunoreactivity.

Purpose of the Study:

  • To investigate the relationship between fungi in naso-sinusal secretions and host immunoreactivity in AFS patients.
  • To clarify the role of IgE-mediated hypersensitivity in the pathophysiology of AFS.

Main Methods:

  • Conducted allergological and otorhinolaryngological evaluations on 24 AFS patients.
  • Performed microscopic examination, fungal culture, skin prick tests (SPT), total and specific IgE serum level analysis, and nasal provocation tests.

Main Results:

  • SPT to fungal allergens were positive in only 16.6% of patients.
  • Elevated total IgE levels were observed in 25% of patients, but specific IgE and eosinophilic cationic protein levels were normal.
  • Nasal provocation tests were negative in all participants.

Conclusions:

  • Fungal presence in nasal secretions is not correlated with allergic status in AFS.
  • IgE-mediated type I hypersensitivity is unlikely to be involved in the etiology or pathophysiology of AFS.
  • Diagnostic criteria for AFS may need reevaluation, excluding type I hypersensitivity as a requirement.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...